Bipolar disorder, homocysteine and white matter hyperintensities.
Amílcar
A
dos Santos
Joaquim Alves
JA
da Silva
Jaime
J
Almeida
Bernardo Barahona
BB
Corrêa
Joaquim
J
Gago
Miguel
M
Xavier
D018692:Antimanic Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000378:metabolism* / Q000473:pathology*; D001921:Brain / Q000473:pathology*; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage; D006220:Haloperidol / Q000627:therapeutic use; D006711:Homocystine / Q000378:metabolism*; D006801:Humans; D016651:Lithium Carbonate / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging / Q000379:methods; D008875:Middle Aged; D009483:Neuropsychological Tests; D014805:Vitamin B 12 / Q000008:administration & dosage
D018692:Antimanic Agents; D014150:Antipsychotic Agents; D016651:Lithium Carbonate; D006711:Homocystine; D005492:Folic Acid; D006220:Haloperidol; D014805:Vitamin B 12